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Pistacia atlantica gum aqueous extract modulates humoral and cellular immune
responses in BALB/c mice
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Abstract: Natural herbal products contain different compounds that can modulate immune and inflammatory diseases. This investigation
aimed to examine the influence of Pistacia atlantica aqueous extract on cellular and humoral immunity in mice following the exposure
to sheep red blood cells (SRBCs). For this purpose, male BALB/c mice (n = 40) were randomly assigned into 4 equivalent groups. The
animals received 1 × 109 SRBCs in complete Freund’s adjuvant (CFA) intraperitoneally 3 times with two-week intervals. Five days after
the final injection, blood samples were taken from the animals. Additionally, 1 × 109 SRBCs were also injected into the mice’s left hind
footpad 48 h before the blood collection. Three groups of mice received various oral doses of the extract (100, 200, and 400 mg/kg)
for 52 consecutive days after the study onset. Measurements were performed on the levels of humoral and cellular immune responses,
splenocytes’ ability to uptake neutral red, respiratory burst, and cell viability. The mice receiving Pistacia atlantica in all concentrations
displayed significantly low delayed type hypersensitivity (DTH) reactions in a dose-dependent manner compared to the control animals.
The treated mice also presented a dose-dependent, significantly lower average anti-SRBC titer than that in the control animals. IL-17
and IL-10 cytokine levels respectively decreased and increased significantly in the mice that received Pistacia atlantica compared to the
control group. Splenocyte proliferation and respiratory burst declined significantly in mice treated with Pistacia atlantica as opposed
to the normal control group but phagocytosis ability was significantly decreased. The immunomodulatory impacts of Pistacia atlantica
might be partially caused by immunity diversion from proinflammatory cytokine IL-17 into antiinflammatory cytokine IL-10.
Key words: Pistacia atlantica, humoral and cellular immunity, immunomodulation, BALB/c mice

1. Introduction
Modern strategies for treating autoimmune diseases have
significantly improved the consequences of these diseases
and raised a novel promise for better recovery [1]. Presently,
immunosuppression is the backbone of autoimmune disease
treatment. Traditional drugs used for treating autoimmune
inflammatory diseases include disease modifying
antirheumatic drugs (DMARDs), glucocorticoids, and
nonsteroidal antiinflammatory drugs (NSAIDs) [2,3].
Natural products such as medicinal plants were used
for the treatment of human diseases many years ago [4].
However, traditional medicine along with modern therapies
continues to be an important basis for future medication
and remedies [5]. Additionally, natural products, consisting
of intrinsically diverse structures (compared with synthetic
compounds), are the main sources of bioactive agents for
developing novel medicines [6,7]. Production of drugs from
medicinal plants has mostly been dependent upon isolation

of materials which are the source of biological activities of
the plants [8].
Pistacia atlantica (from the family Anacardiaceae) as
an indigenous fruit of Iran has been traditionally used in
traditional medicine [9]. This plant has constituents such
as carotenes, tocopherols, and alcohols. Tocopherols and
tocotrienols have antioxidant activity similar to vitamin
E, which is advantageous for human health [10]. Pistacia
atlantica has a variety of beneficial features for treating
diseases such as hepatic, digestive, and neurological
disorders [11,12]. According to Shakarami et al. [13], the
aqueous extract of Pistacia atlantica gum has potential as
a natural medicine for treating asthma. Tanideh et al. [14]
presented evidence that oral and rectal administration of
oil extract from Pistacia atlantica at high doses could lead
to some positive physiological and pathological changes of
colitis in a rat model; thus, it might be effective for treating
ulcerative colitis.
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This study aimed to examine the influence of Pistacia
atlantica gum aqueous extract on cellular and humoral
immunity in mice following immunization by sheep red
blood cells (SRBCs).
2. Materials and methods
2.1. Reagents
Complete Freund’s adjuvant (CFA), natural red, nitro blue
tetrazolium,
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl
tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO),
and phosphate‐buffered saline (PBS) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine
serum and RPMI 1640 were purchased from GIBCO/Life
Technologies Inc. (Gaithersburg, MD, USA). The ELISA
kits for assaying cytokines were purchased from Abcam
(Germany).
2.2. Animals
Male BALB/c mice aged from 6 to 8 weeks old were
provided by the Pasteur Institute, Tehran, Iran. For one
week before the experiments, the animals were kept under
fixed settings of 12 h light/dark photoperiod and under
temperatures of 22–24 °C. The mice were kept under
conditions compatible with the protocols of the Ministry
of Health and Medical Education of Iran. The study was
performed under a license issued by the Medical Ethics
Committee of the Khorramabad University of Medical
Science for Animal Studies (IR.LUMS.REC.1397.165).
2.3. Pistacia atlantica gum extraction
Fresh Pistacia atlantica gum was obtained from
Khorramabad grocery stores (Lorestan, Iran). The gum
was identified and characterized by a herbarium collection
manager at the University of Khorramabad (Herbarium
No. HLu27061397). It was then washed, dried, ground, and
vacuum-dried using an electric mill. The resultant powder
was soaked in distilled water for 48 h before filtration. The
extract was incubated at 50 °C, followed by exposure to
redistillation [15].
2.4. Gas chromatography–mass spectrometry (GC-MS)
analysis
GC-MS examination was done with a Shimadzu GC17A (Kyoto, Japan) gas chromatograph connected
to a Shimadzu Quadruple-MS model QP5050 mass
spectrometer. The mixtures were partitioned on a fused
silica capillary column with dimensions of 30 m × 0.22
mm i.d. covered with a 0.25 µm layer of BP-5 (Shimadzu)
and a split/splitless injector with an internal glass liner
of 1 mm. Ultrapure helium as a carrier gas was utilized
at an ionization voltage of 70 eV. The temperatures of the
injector and interface were 280 °C and 260 °C, respectively.
The mass ranged between 35 and 450 amu. The oven
temperature limit was similar to the one mentioned earlier
for the GC. The extract components were identified in a
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DB5 column under similar chromatographic conditions
through calculating the retention indexes under the
settings based on the temperature for n-alkanes (C8–C20).
The extract components were determined by comparing
their mass spectra with those of the internal reference
mass spectra library (NIST08 and Wiley 9.0) [15].
2.5. The experimental scheme, immunization protocol,
and assessment
The mice were randomly assigned into 4 groups, namely
a control and 3 treatment groups, with 10 animals in
each group. The treatment groups were administered
various amounts of the extract (100, 200, and 400 mg/kg)
via the oral route from the start of the study (beginning
of immunization), maintained continuously during the
survey while taking blood from the animals. The dose
was selected according to the earlier studies with murine
models. Normal control mice were treated with an
equivalent volume of PBS with the same treatment plan
of the test groups. Antigen (1 × 109 SRBCs) was emulsified
in CFA and injected to mice intraperitoneally 3 times
with 2-week intervals. Five days after the final injection,
blood samples of animals were taken from their hearts,
after determining the amounts of the anti-SRBC antibody
in their blood with a microhemagglutination experiment
based on previous studies.
Additionally, to assess cellular immunity, mice were
exposed to subcutaneous injection of 1 × 109 SRBCs in 50
μL of PBS into the left hind footpad 48 h before bleeding
time. At the same time, a similar amount of PBS was
administered into the right footpad of the control group.
Before the bleeding, the thickness of the footpad was
measured using a dial caliper and the average percentage
increase in the thickness of the footpad was established
based on the equation below [16]:
[(left footpad thickness) – (right footpad thickness)] ×
100/ (right footpad thickness)
2.6. Measuring cytokines
Aseptic isolation of spleen cells from mice was performed
at bleeding time. Briefly, single-cell suspensions of
splenocytes were prepared in RPMI 1640 medium
complemented with red blood cells (RBCs) and 10% fetal
bovine serum, eliminated by RBC lysis buffer. Then cell
suspensions (2 × 106 cells/mL) underwent incubation in
plates with 24 wells and were pulsated by PHA solution of
50 μL (1 mg/mL). The culture supernatants were gathered
after 72 h. IL-10 and IL-17 cytokines were assayed by
ELISA test according to the instructions of the provider
of the kits [17].
2.7. Splenocyte proliferation
The proliferation potency of the splenocytes was assessed
by the MTT test. The splenocytes were cultured in 96well, flat-bottomed plates (1 × 105 cells/100 μL/well) in
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RPMI 1640 medium supplemented with 10% fetal bovine
serum, and activated by a PHA solution of 50 μL (1 mg/
mL), or culture medium alone. Following incubation for
72 h, the cultures were pulsed with MTT solution of 20 μL
(5 mg/mL) at 37 °C for 4 h. Afterward, DMSO (150 mL)
was added to dissolve the formazan crystal and agitated
vigorously. The optical density (OD) was read at 550 nm by
a microplate reader (Dynatech, Denkendorf, Germany).
The assays were run in triplicates and the findings were
expressed as the index of proliferation based on the ratio of
the OD550 of the stimulated cells with MOG35-55 to the
OD550 of nonstimulated cells [18].
2.8. Measuring respiratory burst in splenocytes
In splenocyte populations, the phagocytic cells’ respiratory
burst was examined by NBT dye reduction based on
the partially modified previous description of the test
[20–22]. Briefly, a mixture was prepared with splenocyte
suspension (100 μL), Staphylococcus aureus suspension
(108 cell/mL) of 0.1 mL, and 0.1% NBT of 0.1 mL in PBS
(pH 7.4). This mixture underwent incubation for 15 min
at ambient temperature and was then held for a further 15
min at 37 °C. The reduced dye was extracted in dioxane
and quantified at 520 nm [19].
2.9. Phagocytic assay of splenocytes population by neutral red
The primary phagocytic ability of the splenocyte population
(opsonin-independent phagocytosis) was measured
using neutral red uptake through the addition of neutral
red solution (dissolved in 10 mmol/L PBS at a 0.075%
concentration) of 200 µL to the splenocyte population
and incubation of cells for 1 h. After discarding the
supernatant, cells were rinsed 2 times in PBS to eliminate

the neutral red not undergoing phagocytosis by cells. This
was followed by the addition of cell lysate solution (0.01%
acetic acid and ethanol at the ratio of 1:1, 200 µL/well) to
the cells and then incubation at 4 °C nightlong. The optical
density was read at 490 nm by a microplate reader [20].
2.10. Statistical analysis
The data were analyzed with one-way ANOVA and
presented as mean ± standard deviation (SD) to compare
the experimental groups. Once significant differences
were detected by ANOVA, mean values between different
groups were compared by Tukey’s multiple post hoc
test. Differences between the groups were considered
significant at P < 0.05.
3. Results
As represented in Table 1, GC-MS analysis of Pistacia
atlantica gum aqueous extract demonstrated the highest
levels of active ingredients including α-pinene and β-pinene
at 77.9% and 3.66%, respectively. As shown in Table 2,
mice that received different concentrations of Pistacia
atlantica displayed significantly lower DTH reactions dosedependently compared with the control groups. The treated
mice also presented significantly lower average antibody
titers dose-dependently than that in control animals (Table
2). Footpad diameter (indicative of DTH) and antibody
titer were significantly reduced by the concentrations of
100, 200 (P < 0.05), and 400 mg/kg (P < 0.01) of the extract,
and IL-17 cytokine levels decreased significantly while IL10 increased significantly in splenocytes of mice subjected
to Pistacia atlantica in comparison with the cells from the
control group (Table 3). Changes in IL-17 and IL-10 levels
were all dose-dependent.

Table 1. The concentrations (%) of different compounds in aqueous extract of Pistacia atlantica gum.
Compound

RI

Amount (%)

Compound

RI

Amount (%)

Alpha-Pinene

939

77.9

Linalool

1103

0.13

Camphene

953

0.88

Chrysanthenone

1146

0.08

Verbenene

967

0.43

Rans-Limonene-Oxide

1149

0.09

Beta-Pinene

980

3.66

Pinocarveol

1152

0.59

Beta-Myrcene

991

6.26

Cis-Sabinol

1149

1.7

Delta-3-carene

1011

0.24

Isopinocamphone

1181

1.93

Alpha-Terpinene

1018

0.03

Pinocarvone

1162

0.14

P-Cymene

1026

0.3

P-Mentha-1,5-dien-8-ol

1185

0.05

L-Limonene

1031

0.76

Terpinene-4-ol

1190

1.02

1,8-Cineole

1033

0.14

P-Cymen-8-ol

1199

0.25

Trans-beta-Ocimene

1050

0.18

Myrtenol

1190

0.55

Gamma-Terpinene

1062

0.07

Cis-Carveol

1241

0.15

Terpinolene

1088

0.21

Isobornyl acetate

1302

0.2
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Table 2. The effects of the aqueous extract of Pistacia atlantica
gum on humoral (antibody titer) and cellular (percentage of
footpad thickness) DTH reactions (* P < 0.05 and # P < 0.01,
different treated groups in comparison with the control group).
Group

Antibody titer

Percentage of footpad
thickness

Control

448 ± 128

1.975 ± 0.170

100 mg/kg

80 ± 32*

1.5 ± 0.081*

200 mg/kg

40 ± 16*

400 mg/kg

12 ± 4.61

1.375 ± 0.095*
#

1.225 ± 0.170

#

The viability of splenocytes was assessed by MTT
assay, which measured cell metabolic activity. Splenocyte
proliferation (Figure 1) and respiratory burst (Figure
2) dropped significantly in mice treated with Pistacia
atlantica compared to the normal control group.
Viable phagocytic cells engulf neutral red (NR) as a
vital stain and keep it in their lysosomes. The data of the
present study (Figure 3) indicated that treatment of mice
with Pistacia atlantica could significantly potentiate the
opsonin-independent phagocytic ability of splenocytes
dose-dependently.
4. Discussion
Immunity is defined as an ability displayed by animals
against damage induced by microorganisms and their
products [21]. Immunity is generally associated with
the response of the body towards all foreign antigens.
Although immunity is advantageous to host, it may
occasionally be injurious, resulting in tissue injuries and
diseases (hypersensitivity and autoimmune diseases) [22].
Phytochemicals are natural products originating
from plants. A considerable number of phytochemicals
derived from various plants show promise in modulating
immune reactions [23]. Flavonoids, flavanol, quinones,
phloroglucinols, polysaccharides, glycosides, terpenoids,
essential oils, alkaloids, glycolipids, biopolymers,
phenolics, macrocyclic lactones, saponins, cannabinoids,
polyacetylenes, gallic acid, coumarins, lignans, artemisinin,
alpha-amyrin, kaempferol, hexacosanol, and vitamin
C are among the most common phytochemicals. These
phytochemicals lead to a variety of immunomodulating
effects [24]. The present research aimed at examining
the impacts of Pistacia atlantica as a natural product on
BALB/c mice immunized with SRBCs.
Previous studies showed that a high dose of Pistacia
atlantica extract used orally and rectally ameliorated the
physiological and pathological status of colitis, which is
an immune system disorder, in a rat model [14]. Recently,
the use of Pistacia atlantica extract has shown significant
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Table 3. Cytokine production assay following treatment with the
extract of Pistacia atlantica gum. Splenocytes isolated from mice
after immunization with SRBCs were cultured with PHA of 50 µL
(1 mg/mL) for 72 h. The amounts of IL-17 and IL-10 in culture
supernatants were measured by ELISA after 72 h (* P < 0.05 and
# P < 0.01, various treated groups in comparison with the control
group).
Group

IL-17 level

IL-10 level

Control

38.75 ± 5.18

34.5 ± 3.87

100 mg/kg

33 ± 2.16*

42 ± 3.16*

200 mg/kg

31.5 ± 3.41

44.25 ± 2.98*

400 mg/kg

25.75 ± 3.59#

47.5 ± 3.41#

*

increases in antioxidant defense, vascular endothelial
growth factor (VEGF), and hydroxyproline but reduced
amounts of malondialdehyde (MDA) in rats that underwent
experimental skin burns [25]. Moreover, Pistacia atlantica
could markedly decrease wound size in comparison with
burns in the control animals along with greater advantageous
impacts than sulfadiazine as the positive control [25].
Shakarami et al. [13] presented evidence of significant
decreases in the number of bronchoalveolar lavage
fluid (BALF) eosinophilic cells and the amounts of antiovalbumin IgE, IL-4, IL-5, and IL-17 cytokines, as well as
pathologic injury to the lung tissue induced by aqueous
extract of Pistacia atlantica gum. The same authors
further demonstrated significant elevations in the levels of
antiinflammatory IL-10, TGF-β, and INF-γ in the extracttreated groups compared to the asthmatic groups, which
received dexamethasone. As stated above, the extract of
Pistacia atlantica possesses antiinflammatory activities
which act as natural sources in treating immune system
disorders.
Recently published literature has reported that natural
products originating from plants have a major effect on
differentiating T cell subsets and migrating the T cells into
tissues. T cell-mediated immunity has considerable impact
in organ-specific autoimmune diseases [26]. Delayed type
hypersensitivity (DTH) is among the usual reaction patterns
of immunity mediated by T cell. The primary requisite for
DTH response is to prime a particular effector group of
antigen-specific T cells [27].
The initial demonstration of Th17 cells’ contribution
to autoimmunity was in mice with a defective p19 chain
of IL-23, in which T cells generating the IL-17 were
statistically less than those in wild type mice, underlining
the significance of the IL-23/Th17 axis in the pathogenicity
of these autoimmune diseases [28].
IL-17 (known as IL-17A as well) has strong
proinflammatory activity, making it a critical agent in

ESMAEILI GOUVARCHIN GHALEH et al. / Turk J Vet Anim Sci

0.8

*

Prolifration index

0.7
0.6

*

0.5

#

0.4
0.3
0.2
0.1
0

Control

100 mg/kg

200 mg/kg

400 mg/kg

Figure 1. Assessment of mice splenocyte proliferation following challenging of
the immune system with SRBCs and treatment by Pistacia atlantica gum extract
(* P < 0.05 and # P < 0.01, various treated groups in comparison with the control
group).
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0.6

*

0.5

*

0.4
0.3

#

0.2
0.1
0

Control

100 mg/kg

200 mg/kg

400 mg/kg

Figure 2. Assessment of splenocytes respiratory burst in mice following the
exposure of the immune system to SRBCs and treatment by Pistacia atlantica gum
extract (* P < 0.05 and # P < 0.01, various treated groups in comparison with the
control group).

regulating DTH reactions. Apparently, Th17 cells mimic
the inflammatory reaction and regulate the tissue injury. It
generally appears that Th17 cells have higher pathogenicity
than other cells in immunopathological settings [29].
According to the findings of this study, IL-17
production was significantly decreased by treatment with
Pistacia atlantica following immunization of mice with
SRBCs. DTH response was also reduced by this extract.
Our results present a new understanding of the possible
mechanisms that underlie the immunomodulatory
impacts of Pistacia atlantica.
As an immunoregulatory cytokine, IL-10 has a critical
contribution to inflammatory and immune reactions,

termination of macrophage activity in DTH responses,
and subsequently the prevention of tissue damage [30].
This cytokine shows strong immunosuppressive and
antiinflammatory activities on myeloid cell function,
providing a concrete foundation to be applied in acute
and chronic inflammatory illnesses. Suppression of the
immunostimulatory activities of IL-10 can furnish new
strategies in treating humoral autoimmune diseases,
infectious diseases, and cancer [30]. The results showed
a decrease in IL-17 production and an increase in IL-10
production by Pistacia atlantica extract, which might
justify the respiratory burst reduction in splenocytes of
mice under Pistacia atlantica treatment.
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Figure 3. Assessment of neutral red uptake by mice splenocytes following the
exposure of the immune system to SRBCs and treatment by the extract of Pistacia
atlantica gum (* P < 0.05 and # P < 0.01, various treated groups in comparison with
the control group).

Reactive oxygen species (ROS) have a crucial
contribution to the elimination of invading microorganisms
by phagocytes. Nonetheless, upon increased or unsuitable
production, ROS are engaged in acute host tissue damage
and other immunopathological situations [14].
Notably, in the investigation by the authors, the mice
showed increased phagocytic activity and uptake of neutral
red under Pistacia atlantica gum extract treatment, with
significant drops in respiratory burst against opsonized
heat-killed baker’s yeast and splenocyte proliferation.
The findings of respiratory burst, neutral red, and
MTT assays demonstrated that despite an improvement
in phagocytosis ability of spleen cells in the mice treated
with Pistacia atlantica gum, there were reductions in
their killing activity and proliferation, suggesting an
induction of bodily antiinflammatory ability as a result
of this treatment. In conclusion, our results revealed that
Pistacia atlantica gum has immunomodulatory effects in

the mouse model and it can be used in the treatment of
autoimmune diseases as a natural product.
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